AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking AwayAllbiopro2018-10-26T10:55:22+09:0010월 26th, 2018|
Roche Snags FDA Approval for First New Flu Drug in 20 YearsAllbiopro2018-10-26T10:54:30+09:0010월 26th, 2018|
Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian CancerAllbiopro2018-10-26T10:53:38+09:0010월 26th, 2018|
Elpis Biomed Human Cell Models Could Potentially Replace Animal Experiments in Drug DiscoveryAllbiopro2018-10-26T10:52:44+09:0010월 26th, 2018|
Johnson & Johnson steps up vaccines R&D—and prepares for launches—with €72M plantAllbiopro2018-10-26T10:51:51+09:0010월 26th, 2018|
Trump targets ‘global freeloading’ with push to match cheaper overseas drug pricesAllbiopro2018-10-26T10:50:58+09:0010월 26th, 2018|
Regeneron gets CRL as it shoots for approval of Eylea in diabetic eye diseaseAllbiopro2018-10-26T10:50:04+09:0010월 26th, 2018|
Vertex CEO says its competitive edge is honed and ready for AbbVie’s cystic fibrosis grabAllbiopro2018-10-26T10:49:12+09:0010월 26th, 2018|
Opdivo will keep growing, Bristol-Myers says, trying to talk investors off the ledgeAllbiopro2018-10-26T10:48:17+09:0010월 26th, 2018|
OrbiMed launches NASH-focused 89Bio with $60M series A, Rohan Palekar as CEOAllbiopro2018-10-26T10:47:23+09:0010월 26th, 2018|
EuroBiotech Report—AstraZeneca-Innate, Galapagos, Enterome, GlaxoSmithKline and Bayer Allbiopro2018-10-26T10:45:34+09:0010월 26th, 2018|
Thermo Fisher services biz up 28% as Patheon enters the mixAllbiopro2018-10-26T10:44:35+09:0010월 26th, 2018|
Janssen closing in on ‘holy grail’ through $82m HIV vaccine plantAllbiopro2018-10-26T10:43:38+09:0010월 26th, 2018|
‘Mushrooms’ and ‘brushes’ help cancer-fighting nanoparticles survive in the bodyAllbiopro2018-10-26T10:41:04+09:0010월 26th, 2018|
Anti-aging molecule NAD+ gets a boost from blocking an enzymeAllbiopro2018-10-26T10:40:10+09:0010월 26th, 2018|
